Biologics and Biosimilars Market Size & Analysis for North America, Europe, APAC, South America, Middle East and Africa - US, UK, France, Germany, China – 2025-2029

Biologics and Biosimilars Market Outlook 2025-2029

The global biologics and biosimilars market is experiencing rapid growth, driven by advancements in biotechnology, increasing prevalence of chronic diseases, and rising demand for innovative therapies. The market is projected to reach a value of USD 50-60 billion by 2024, with a CAGR of 15%-20% from 2025 to 2029. Exact values for this market can be accessed upon purchasing the report.

To access the full market forecast and comprehensive analysis, Buy Now

Market Segmentation

The market is segmented based on:

• Product Type:
  • Monoclonal Antibodies
  • Vaccines
  • Hormones
  • Growth Factors
• Therapeutic Area:
  • Oncology
  • Immunology
  • Infectious Diseases
  • Neurology

Market Dynamics

• Driver: The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is a major driver for the market.
• Challenge: High research and development costs, complex manufacturing processes, and stringent regulatory requirements pose challenges to market growth.
• Trend: The development of biosimilars to reduce the cost of biologics and improve access to innovative therapies is a prominent trend.

Regional Analysis

• North America: Strong research and development infrastructure and high healthcare expenditure drive market growth.
• Europe: Mature pharmaceutical market with a focus on innovation and patient-centric healthcare.
• Asia-Pacific: Rapidly growing healthcare sector, increasing prevalence of chronic diseases, and growing demand for affordable healthcare solutions.

Competitive Landscape

The biologics and biosimilars market is highly competitive, with key players such as Amgen, Roche, Novartis, and Pfizer. These companies are investing heavily in research and development to develop innovative biologics and expand their market share.

Market Scope

For further information, Get Free Sample

Customization Purview

Technavio offers customization options to meet specific client requirements, including detailed analysis of specific segments, regions, or companies.

How Technavio's Market Research Can Benefit Your Business

• In-depth market analysis and forecasts
• Identification of key growth drivers and challenges
• Analysis of competitive landscape and market trends
• Customized research to meet specific needs

FAQs

1. Which region dominates the global biologics and biosimilars market? North America dominates the global biologics and biosimilars market.
2. What are the major drivers of the biologics and biosimilars market? The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is a major driver.
3. What are the key challenges faced by the biologics and biosimilars market? High research and development costs, complex manufacturing processes, and stringent regulatory requirements pose challenges to market growth.
4. What are the major trends shaping the biologics and biosimilars market? The development of biosimilars to reduce the cost of biologics and improve access to innovative therapies is a prominent trend.

Table of Contents

1. Executive Summary
2. Scope of the Report
3. Market Landscape
4. Market Sizing
5. Historic Market Size (2019-2023)
6. Impact of AI on the market
7. Five Forces Analysis
8. Market Segmentation by Product Type
9. Market Segmentation by Therapeutic Area
10. Market Segmentation by Region
11. Customer Landscape
12. Drivers and Challenges
13. Market Trends
14. Vendor Landscape and Vendor Analysis
15. Appendix (Methodology, abbreviations)